News

Exciting €295.5 Million Investment in Bauxite and Alumina

Exciting €295.5 Million Investment in Bauxite and Alumina

Major Investment by METLEN in Bauxite and Alumina Production

Development of an Integrated Production Line for Bauxite, Alumina, and Gallium

  • Investment Plan of €295.5 million
  • Total Annual Production Capacity of 1,265,000 tonnes of alumina, 50 MT of Gallium, and ~2 million tonnes of bauxite
  • Full substitution of Gallium imports in Europe
  • Improvement of trade balance through increased exports

METLEN Energy & Metals has enthusiastically announced a groundbreaking investment decision amounting to €295.5 million aimed at scaling up the production of crucial materials including bauxite, alumina, and Gallium. This decision, made during a joint session by the Metallurgy and Capital Allocation Committees, marks a transformative moment for the company and the metallurgy sector at large.

This ambitious project will be located at the historic aluminium plant, emphasizing the strategic importance of elevating production capacity while introducing Gallium in industrial production lines, a material pivotal for the future of Europe.

The investment is structured to achieve an impressive annual production capacity of 2 million tonnes of bauxite, a jump from the current 865,000 tonnes to 1,265,000 tonnes for alumina, along with 50 MT of Gallium produced for the first time. These materials hold a critical role on the European Union's list of Critical Raw Materials (CRMs).

The planned investment includes several key components:

  • Development of fresh research initiatives and new bauxite mining deposits,
  • Construction of new production facilities and machinery for Gallium,
  • Expansion and modernization of alumina production units,
  • Enhancements to energy supply infrastructure for the industrial site,
  • Port expansion and upgrade projects,
  • Infrastructure improvements including roads and flood protection.

Evangelos Mytilineos, Chairman and CEO of METLEN, expressed his commitment saying, "This decision to advance a significant industrial investment in bauxite and alumina production not only improves Europe’s self-sufficiency in critical materials but also fortifies Greece’s position on the global stage. This project reinforces our pledge to drive forward a sustainable and innovative approach to industrial production. It emphasizes METLEN's commitment towards supporting a greener economy while reducing dependency on external resources."

A special focus lies on Gallium, which is derived primarily from bauxite during alumina refining. Most Gallium production has been concentrated in China, leading to vulnerabilities when export restrictions were pursued. METLEN's initiative will ensure that Europe no longer depends on imports for Gallium, thereby enhancing its strategic autonomy and supporting development in essential technologies across various sectors including energy and defense.

The products generated by this investment, valued around €1 billion, will be aimed at both the European and North American markets, heralding a new era of competitiveness and innovation.

Furthermore, this initiative underlines METLEN's dedication to environmentally conscious practices, implementing advanced technologies that aim to minimize carbon emissions and ensure sustainable energy consumption.

As part of its commitment, METLEN has submitted this project under Greece's Strategic Investments Law and has gained recognition from the European Commission for its integral role in fortifying the EU's self-sufficiency in CRMs.

Expected timelines for completion of the project indicate that bauxite production will commence by 2026, with alumina and Gallium production expected to begin progressively from 2027, reaching full operation by 2028.

About METLEN: METLEN Energy & Metals is a multinational leader in the metallurgy and energy sectors. With a significant emphasis on sustainability and innovation, METLEN operates the only vertically integrated bauxite, alumina, and primary aluminium production unit within the European Union, signifying its strategic importance in competitive metallurgy. The company, a part of the Athens Stock Exchange, thrives across 40 countries, furthering its model of synergy between its Metallurgy and Energy sectors.

Frequently Asked Questions

What is METLEN's latest investment focus?

METLEN's latest investment focuses on enhancing the production capacity of bauxite, alumina, and Gallium with an investment of €295.5 million.

Why is this investment significant for Europe?

This investment will allow Europe to reduce its reliance on Gallium imports, promoting self-sufficiency in critical raw materials essential for various industries.

What materials will be produced under this investment?

The investment will yield 2 million tonnes of bauxite, 1,265,000 tonnes of alumina, and 50 MT of Gallium annually.

How does this project align with sustainability goals?

The investment incorporates environmentally friendly technologies and aims to reduce the facility's carbon footprint, aligning with sustainable practices.

When is the expected start of production?

Bauxite production is expected to begin in 2026, while alumina and Gallium production will start from 2027, reaching full operation by 2028.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles